Dear Excipients Insight readers,
Welcome to the last edition of our newsletter for 2018. And a bumper edition it is!
It’s hard to believe that the year has passed so quickly and of course, it’s that time when we reflect on we did, what remains to be done and where to next?! First and foremost, and perennially, we remain ever thankful for those members who contribute so much to our efforts.Read more
Dear Excipients Insight readers,
Welcome to the latest edition of our newsletter.
As I think of what’s been happening in recent weeks, once more we are in a hurry to consider some draft guidance documents from the China Pharmacopoeia (ChP) Commission on excipients of animal origin and excipient suitability studies. These have been distributed to our IPEC Europe members and relevant committees, and as I’ve mentioned before we greatly appreciate your contributions in very short turnaround times.Read more
Welcome to our latest edition and as this is hot-on-the-heels of the IPEC Europe Board meeting, we’ve been able to capture a few highlights for you here. After the summer break it’s time to kick off activities to ensure we meet our 2018 goals and indeed, prepare for next year. Effectively we have only three months left so we task out committees and working groups to make their best efforts to close out projects and develop plans for 2019 and beyond.Read more
It is unusual to be writing an editorial in August itself which is, as for many of you, our ‘holiday’ period. So, always striving to do something different, publishing this week does allow me to stay that despite our assumption that little gets done in the summer months, in fact it seems quite the opposite, for 2018 at least.Read more
It’s hard to believe that we’re issuing our June publication already and we find ourselves heading for the summer break. And of course, we’re now preparing for those mid-year reviews to measure progress to ensure we can meet our goals by the end of the year. Not only that but September is not far away when the Board will convene with an eye to 2019. We’ll be revisiting our Agenda 2020 to confirm our strategic direction and that we’re working on the right things to get there. More on this in future issues.Read more
Welcome readers to our spring edition!
Reflecting on what has happened during the past two months, again I am drawn to the subject of regulations, and not just those that impact directly or indirectly on pharmaceutical excipients. Surprisingly, I’m talking about those areas where we wish there might be some regulatory processes in place to better protect the intellectual property of particularly, novel excipients.Read more
Hello Excipients Insight readers,
As the first quarter of 2018 comes to a close, I’m glad to report that while we have set in place our plans for this year, many activities are ongoing. After our annual event in Bordeaux, we’ve had our first ‘outing’ to present the association at Europe’s First Making Pharmaceuticals event in Brussels earlier this month. IPEC Europe contributed to the speaker programme through Dr Liz Meehan and Astrid Stockrahm-Uhling, to whom we offer our thanks for spreading the word on excipient developments.Read more
Already at the end of this year’s second month, we have a packed edition of our newsletter for you which features several reports of our recent events in Bordeaux, France. Hopefully, for those who weren’t able to attend it will provide some great information - and for those who were there perhaps some nice reminders which you can share with colleagues.Read more
As this is our opening edition of Excipients Insight for 2018, on behalf of the IPEC Europe Board, I’d like to wish all reading this a most successful and rewarding New Year. It will be a very busy one no doubt, as for sure the number of challenges we face as an ‘industry’ do not seem to be in decline!Read more